Brief: Onward Medical Awarded Device Designation For Brain-Computer Interface From US FDA
29/02/2024 06:45
Feb 29 (Reuters) - Onward Medical NV ONWD.BR :
* AWARDED 10TH BREAKTHROUGH DEVICE DESIGNATION FOR
BRAIN-COMPUTER
INTERFACE (BCI) FROM US FDA
* THIS BDD IS SUPPORTED BY CLINICAL DATA FROM TWO
FEASIBILITY
STUDIES
* THIS LATEST AWARD GIVES ONWARD MEDICAL PRIORITY FDA REVIEW
Source text for Eikon: ID:nGNE957Pdv
Further company coverage: ONWD.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ONWARD Medical
See all newsBrief: Onward Medical Primary ABB Final Deal Size Was C.Eur 50m / 11.3m Shares, Says Bookrunner
Brief: Ottobock Invests EUR 10 Million In Onward Medical
Brief: Bookrunner Says Onward Medical Primary ABB Books Covered, Further Guidance To Follow
Brief: ONWARD Medical Receives FDA De Novo Classification
Brief: Onward Medical Says Receives FDA De Novo Classification And US Market Authorization For ARC-EX System